Insulin Glargine in Type 2 Diabetes
NCT00268645 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 534
Last updated 2011-01-11
Summary
The aim of this project is to confirm the efficacy and safety profile of Insulin glargine in daily practice and to improve the physicians' knowledge and experience concerning Insulin glargine
Conditions
- Diabetes Mellitus, Type 2
Interventions
- DRUG
-
Insulin Glargine
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Edibe Taylan · Sanofi
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-09-30
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Safety and Effectiveness Study of Insulin Glargine (LANTUS) Initiation and Titration in Patients With Type 2 Diabetes
NCT01127269 ·Status: COMPLETED ·Phase: PHASE4
-
Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment
NCT00046462 ·Status: COMPLETED ·Phase: PHASE3
-
20 Week Bridging Study in Type II DM
NCT00563225 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey
NCT02954692 ·Status: COMPLETED ·Phase: PHASE4
-
LANTUSTITR: Insulin Glargine in Type 2 Diabetes Mellitus
NCT00349986 ·Status: TERMINATED ·Phase: PHASE4
-
A Clinical Study to Compare the Efficacy and Safety of a Novel Medicine (NNC0268-0965) With Insulin Glargine
NCT04575181 ·Status: COMPLETED ·Phase: PHASE1
-
Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study
NCT01121835 ·Status: COMPLETED ·Phase: PHASE4
-
Glulisine + Lantus in Type I Patients
NCT00545337 ·Status: COMPLETED ·Phase: PHASE3
-
PK/PD Study of Gan & Lee's Insulin Glargine Injection in Comparison to Lantus in Type 1 Diabetes
NCT02506647 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison Safety and Efficacy of Basal Insulin Lantus® (Insulin Glargine) vs NPH Insulin in Combination With Oral Antidiabetic Drugs (OADs) in Patients With Diabetes Mellitus, Type 2 (DMT2)
NCT00659477 ·Status: COMPLETED ·Phase: PHASE4
-
Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus
NCT00467376 ·Status: COMPLETED ·Phase: PHASE3
-
Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus (T1DM) Patients
NCT02666430 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy
NCT01499095 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes
NCT01849289 ·Status: COMPLETED ·Phase: PHASE3
-
Pre-Mix Insulin Lispro Treatment for Type 2 Diabetes Patients Who Consume a Light Breakfast
NCT00664534 ·Status: COMPLETED ·Phase: PHASE4
-
Insulin Glargine During and After the Period of Fasting in Ramadan
NCT00258804 ·Status: COMPLETED ·Phase: PHASE4
-
An Open Therapeutic Project to Confirm the Efficacy Tolerability and Safety Profile of Lantus in Everyday Medical Practice
NCT00576368 ·Status: COMPLETED ·Phase: PHASE4
-
Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2)
NCT02227875 ·Status: COMPLETED ·Phase: PHASE3
-
Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-study: "HALT"(Hypoglycaemia Avoidance With Lantus Trial)
NCT00390728 ·Status: COMPLETED ·Phase: PHASE4
-
A Study in Participants With Type 2 Diabetes Mellitus
NCT01468987 ·Status: COMPLETED ·Phase: PHASE3
-
PK/PD Biosimilarity Study of Gan & Lee Insulin Glargine Injection vs.US & EU Lantus® in Type 1 Diabetes Mellitus Patients
NCT04236895 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Patients With Type 2 Diabetes Mellitus
NCT01435616 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Adults With Type 1 Diabetes
NCT01421147 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Adults With Type 2 Diabetes
NCT01421459 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Effectiveness and Safety of Physician Versus Patient-led of Insulin Glargine Initiation and Titration in Type 2 Diabetes Mellitus
NCT01169818 ·Status: COMPLETED ·Phase: PHASE4